All tools and calculators

Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
CLEARSIDE BIOMEDICAL INC
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Clearside BiomedicalEli Lilly
Last price
$0.25$1,427.28
Currency
USD
USD
$17M$1.3T
-46.65
-$5.05$30.81
1.870.39
0$6.69
00.48%
Sector
HealthHealth
Employees
3250,000
Ticker
$CLSDQ$LLY
Primary listing
OTCNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $CLSDQ or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.
Sign up